We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Procyrion Stock

Invest in or calculate the value of your shares in Procyrion or other pre-IPO companies through EquityZen's platform.

Get Started

Procyrion Stock (PROY)

Procyrion develops technology solutions and offers a catheter-based circulatory support technologies.

About Procyrion Stock

Founded

2005

Headquarters

Houston, TX, US

Industries

Software, Artificial Intelligence, Data and Analytics

Procyrion develops technology solutions and offers a catheter-based circulatory support technologies. One in five adults over the age of 40 will develop heart failure in his or her lifetime. For the sickest patients, only 1% receive treatment annually due to scarcity, cost, and high risk of current solutions. Procyrion, has developed a solution: Aortix is a circulatory support pump implanted without surgery. Thinner than a #2 pencil, a cardiologist can implant Aortix through a catheter in the leg, deploying it between the heart and the kidneys to unload the failing heart and perfuse vital organs. This first-in-class device allows the heart to rest and heal while correcting the fluid imbalance. The company was founded in 2005 and is based in Houston, Texas.

Procyrion Press Mentions

Stay in the know about the latest news on Procyrion

Procyrion Management

Leadership team at Procyrion

President & CEO

Benjamin A. Hertzog

Chief Operating Officer

Jason Heuring

Locked Features

Join now and verify your accreditation status to gain access to:

  • Procyrion current valuation
  • Procyrion stock price
  • Available deals in Procyrion and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Procyrion stock?

Accredited investors can buy pre-IPO stock in companies like Procyrion through EquityZen funds. These investments are made available by existing Procyrion shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Procyrion stock?

Shareholders can sell their Procyrion stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."